Antiviral therapy for polyomavirus-associated nephropathy after renal transplantation
Open Access
- 18 July 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 62 (5) , 855-859
Abstract
Polyomavirus-associated nephropathy (PVAN) has recently emerged as an important cause of allograft failure following renal transplantation. The BK virus is the most important polyomavirus associated with this condition. The mainstay of therapy for PVAN is a prompt immunosuppressive dose reduction in conjunction with careful monitoring for BK viraemia. A number of antiviral agents have been tried to help to reduce BK viral replication. So far, there has been only a single randomized controlled study on the use of one of these agents. Pooled data from various small case series did not show significant differences in outcome. Prospective randomized studies with a standardized protocol are urgently required.Keywords
This publication has 42 references indexed in Scilit:
- Front MatterAmerican Journal of Transplantation, 2008
- Successful Treatment of BK Viremia Using Reduction in Immunosuppression Without Antiviral TherapyTransplantation, 2008
- Outcome of management strategies for BK virus replication in pediatric renal transplant recipientsPediatric Transplantation, 2007
- Immunosuppression reduction for BK virus nephropathy: a case for cautionTransplant Infectious Disease, 2007
- Rho-Associated Kinase Inhibitor Reduces Tumor Recurrence After Liver Transplantation in a Rat Hepatoma ModelAmerican Journal of Transplantation, 2007
- Urine cytology screening for polyoma virus infection following renal transplantation: the Oxford experienceJournal of Clinical Pathology, 2006
- Recovery and Utilization of Deceased Donor Kidneys from Small Pediatric DonorsAmerican Journal of Transplantation, 2006
- Ciprofloxacin Decreased Polyoma BK Virus Load in Patients Who Underwent Allogeneic Hematopoietic Stem Cell TransplantationClinical Infectious Diseases, 2005
- BK Nephropathy in Kidney Transplant Recipients Treated with a Calcineurin Inhibitor-Free Immunosuppression RegimenAmerican Journal of Transplantation, 2004
- BKV in Simultaneous Pancreas-Kidney Transplant Recipients: A Leading Cause of Renal Graft Loss in First 2 Years Post-TransplantAmerican Journal of Transplantation, 2004